SARS-CoV-2

Getting the elderly vaccine first for COVID-19 saves most lives

Older people at higher risk of Covid-19 relapse, new study says

Researchers are studying differences in reactions to SARS-CoV-2 infection between children and adults

New research suggests innovative antibody-based treatment to prevent viral infiltration of SARS-CoV-2

Living with a COVID-19 case results in worse symptoms and a stronger antibody response

Colombia’s new SARS-CoV-2 line shares antibody-resistant mutations with other modifications

Novavax Covid-19 vaccine performs well in clinical trials, but variables are still at risk

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

COVID-19 pandemic disease affects the quality of care given to new and sick babies

Examination of post-acute sequelae of SARS-CoV-2 infection shows 8-month persistent symptoms